Timothy E. Guertin - 24 Sep 2021 Form 4 Insider Report for TERADYNE, INC (TER)

Role: Director
Signature: /s/ Ryan E. Driscoll, Attorney-in-Fact
Issuer symbol: TER
Transactions as of: 24 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 18 Oct 2021, 21:35:59 UTC
Previous filing: 11 May 2021
Next filing: 04 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TER	Common Stock	Other	$0	+46	+0.06%	$0.000000	72,258	24 Sep 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents deferred stock units ("DSUs") issued to the Reporting Person in accordance with his election to receive dividends paid on DSUs in the form of additional DSUs in lieu of cash. Such acquisition is exempt under Exchange Act Rule 16b-3(d). DSUs are settled one-for-one in Common Stock generally within ninety days of the date as of which a non-employee director no longer serves in such capacity.
F2	Adjusted to reflect the issuance of 2,182 DSUs to the Reporting Person prior to September 24, 2021 in accordance with his election to receive dividends paid on DSUs in the form of additional DSUs in lieu of cash. Such acquisitions were exempt under Exchange Act Rule 16b-3(d).

Content

Represents deferred stock units ("DSUs") issued to the Reporting Person in accordance with his election to receive dividends paid on DSUs in the form of additional DSUs in lieu of cash. Such acquisition is exempt under Exchange Act Rule 16b-3(d). DSUs are settled one-for-one in Common Stock generally within ninety days of the date as of which a non-employee director no longer serves in such capacity.

Adjusted to reflect the issuance of 2,182 DSUs to the Reporting Person prior to September 24, 2021 in accordance with his election to receive dividends paid on DSUs in the form of additional DSUs in lieu of cash. Such acquisitions were exempt under Exchange Act Rule 16b-3(d).